DIVERSIFIED HEALTHCARE TRUST (DHC) reported that director Adam D. Portnoy had common shares withheld on September 17, 2026 to pay taxes due upon vesting of equity awarded under Rule 16b-3. The tax liability was satisfied by withholding 19,315 shares at $8.13 per share, leaving him with 467,923.55 common shares held directly and 23,250,019 shares held indirectly through ABP Trust, for which he disclaims beneficial ownership except to the extent of his pecuniary interest. No Rule 10b5-1 trading plan is reported.
DIVERSIFIED HEALTHCARE TRUST (DHC) reported that its CFO and Treasurer, Matthew C. Brown, had 13,895 Common Shares of Beneficial Interest withheld on September 17, 2026 to satisfy tax liabilities related to a vesting equity award, as permitted under Rule 16b-3. The shares were valued at $8.13 per share for this tax-withholding transaction, and Brown now holds 153,109 shares directly.
DIVERSIFIED HEALTHCARE TRUST (DHC) reported that President and CEO, and director, Christopher J. Bilotto had 25,118 common shares of beneficial interest withheld on September 17, 2026 to pay tax liability upon vesting of equity compensation under Rule 16b-3. After this tax-withholding disposition, he holds 314,066.96 shares directly. No Rule 10b5-1 trading plan is reported.
DIVERSIFIED HEALTHCARE TRUST (symbol: DHC) is the issuer of record for a Form 4 filing submitted to the SEC. PORTNOY ADAM D. reported acquisition or exercise transactions in this Form 4 filing.
DIVERSIFIED HEALTHCARE TRUST (DHC) reported that director Adam D. Portnoy received an award of 59,681 common shares of beneficial interest on September 10, 2026 under the company’s equity compensation plan. Following this grant, he holds 487,238.55 shares directly and has additional indirect ownership through ABP Trust, subject to a beneficial ownership disclaimer.
DIVERSIFIED HEALTHCARE TRUST (symbol: DHC) is the issuer of record for a Form 4 filing submitted to the SEC. Brown Matthew C. reported acquisition or exercise transactions in this Form 4 filing.
DIVERSIFIED HEALTHCARE TRUST (DHC) reported that its Chief Financial Officer and Treasurer, Matthew C. Brown, received an award of 53,050 Common Shares of Beneficial Interest on September 10, 2026. The award was granted under the company’s equity compensation plan, increasing his direct holdings to 167,004 shares.
DIVERSIFIED HEALTHCARE TRUST (DHC) reported that President and CEO Christopher J. Bilotto received an award of 59,681 common shares of beneficial interest on September 10, 2026, as an equity grant under the company’s equity compensation plan.
Following this award and related changes, he now directly holds a total of 339,184.96 shares, including 256.99 shares previously acquired through the dividend reinvestment plan; 0.475 fractional shares from that plan were sold for cash. No Rule 10b5-1 trading plan is indicated.
Diversified Healthcare Trust received an updated ownership report from FF Hybrid, LP, Flat Footed LLC and Marc Andersen. FF Hybrid, LP reports beneficial ownership of 18,054,554 common shares, representing 7.5% of the class. Flat Footed LLC and Marc Andersen each report beneficial ownership of 23,487,002 common shares, or 9.7% of the class, based on 242,106,926 shares outstanding as of April 30, 2026.
The reporting persons indicate shared voting and dispositive power over their reported shares and no sole voting or dispositive power. Flat Footed LLC is an SEC-registered investment adviser and acts as investment manager to FF Hybrid, LP and other funds, which hold the securities for the benefit of their investors. The funds have the right to receive dividends and sale proceeds, and they expressly disclaim beneficial ownership under Rule 13d-4.
Diversified Healthcare Trust investor H/2 Special Opportunities IV L.P. filed an amended Schedule 13D reporting that it now beneficially owns 12,067,366 common shares, representing 4.98% of the outstanding shares as of August 10, 2026. As a result, the reporting person ceased to be a beneficial owner of more than five percent of the shares on that date, and this amendment is stated to be the final amendment to the prior Schedule 13D.
The filing notes that earlier correspondence from an affiliate regarding a proposed merger with Office Properties Income Trust is no longer relevant because that merger agreement was mutually terminated and the transaction was abandoned. The reporting person reports broker-dealer sales totaling 750,000 shares on August 4, 5, and 10, 2026 at prices between $8.40 and $9.15 per share, and confirms no other share transactions in the prior 60 days.
Diversified Healthcare Trust reported Q2 2026 total revenues of $365,387 (thousands), down from $382,712 (thousands) a year earlier, and a narrowed net loss of $37,419 (thousands) versus $91,639 (thousands). For the first half, revenues were $731,858 (thousands) with a net loss of $80,694 (thousands).
The Senior Housing Operating Portfolio (SHOP) generated Q2 residents fees and services of $317,921 (thousands); comparable SHOP communities saw 6.6% revenue growth and higher occupancy and rates, while total SHOP revenue declined due to asset sales. SHOP occupancy for all properties reached 82.5%, with an average monthly rate of $5,693.
The Medical Office and Life Science Portfolio produced Q2 rental income of $40,116 (thousands), with comparable occupancy of 95.8% and positive leasing spreads; weighted average rental rates on 1H 2026 leasing rose 8.1%. Consolidated Q2 net operating income increased to $84,443 (thousands) from $70,132 (thousands), helped by lower interest expense of $37,083 (thousands) versus $50,926 (thousands) after prior-year refinancings.
At June 30, 2026, total assets were $4,238,698 (thousands) and shareholders’ equity was $1,582,831 (thousands). Cash and restricted cash totaled $136,196 (thousands); there were no borrowings on the secured revolving credit facility, with $150,000 available. The company paid $0.02 per share in common distributions in 1H 2026 and declared an additional $0.01 per share for Q3.
Diversified Healthcare Trust reported second quarter 2026 results for the quarter ended June 30, 2026. Total revenues were $365,387 (dollars in thousands) versus $382,712 a year earlier. GAAP net loss narrowed to $37,419 (thousand), or $(0.16) per share. Normalized FFO rose to $38,896 (thousand), also $0.16 per share, while consolidated NOI increased to $84,443 (thousand) and Adjusted EBITDAre to $82,082 (thousand).
Performance improved notably in the senior housing operating portfolio: same property SHOP NOI grew 37.2% year over year to $51,975 (thousand), with margins at 17.3% and occupancy at 83.1%. The Medical Office and Life Science portfolio achieved same property occupancy of 95.8% and approximately 477,000 square feet of new and renewal leasing at rents 6.7% above prior levels.
Leverage metrics strengthened, with net debt to annualized Adjusted EBITDAre improving to 7.1x and interest coverage to 2.2x. As of June 30, 2026, DHC owned a $6,262,230 (thousand) healthcare real estate portfolio of 285 properties. The company declared a quarterly common distribution of $0.01 per share and reaffirmed full year 2026 guidance, including Total NOI of $307,000–$323,000 and Normalized FFO of $135,000–$150,000 (thousands) or $0.56–$0.62 per share.